C4 Therapeutics CCCC
NASDAQ CCCC
$2.89 -0.11 (-3.67%)
At close: Nov 11, 2026 · 4:00 PM EST

C4 Therapeutics (CCCC) Other Operating Expenses (2021 - 2025)

Updated

C4 Therapeutics (CCCC) posted Other Operating Expenses of $10.73 million for FY2025.

Analysis

C4 Therapeutics (CCCC) Other Operating Expenses (2021 - 2025) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 C4 Therapeutics 393.93 Mn -549.34 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2025 10.73 Mn
Mar 31, 2022 90,000.00
Mar 31, 2021 94,000.00
API Access

C4 Therapeutics Other Operating Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-operating-expenses&ticker=CCCC&period=max&api_key=YOUR_API_KEY